 Biodefense Market Insights, Competitive Landscape, and Market Forecast - 2033
The global biodefense market is steadily advancing as nations prioritize preparedness against biological threats ranging from pandemics to potential bioterrorism incidents. The market is projected ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global biodefense market is steadily advancing as nations prioritize preparedness against biological threats ranging from pandemics to potential bioterrorism incidents. The market is projected to reach US$ 13.3 billion in 2026 and is expected to grow to US$ 18.8 billion by 2033, registering a CAGR of 5.10% over the forecast period. Increasing concerns over biosecurity, coupled with rising investments in healthcare resilience and national defense programs, are shaping the trajectory of the biodefense industry. The scope of biodefense extends across detection systems, vaccines, therapeutics, and integrated surveillance networks designed to mitigate risks associated with biological hazards.Market Insights The biodefense market is witnessing significant transformation driven by the convergence of healthcare, defense, and digital technologies. Governments worldwide are enhancing their capabilities to detect, prevent, and respond to biological threats in real time. The growing integration of advanced analytics, artificial intelligence, and molecular diagnostics is improving the accuracy and speed of threat identification. Public-private partnerships are becoming increasingly prominent, enabling faster innovation and deployment of solutions. Moreover, the experience of recent global health crises has reinforced the importance of maintaining robust biodefense infrastructure, leading to sustained funding and policy support across major economies. Drivers The market is primarily driven by the rising threat of biological warfare and the increasing risk of infectious disease outbreaks. Governments are strengthening their defense mechanisms through investments in advanced biosurveillance systems and countermeasure development. Rapid advancements in biotechnology, including vaccine platforms and genomic sequencing, are significantly enhancing biodefense capabilities. Another important driver is the growing adoption of AI-assisted surveillance systems, which enable early detection and rapid response. Additionally, international collaborations and regulatory initiatives aimed at improving global health security are contributing to the expansion of the biodefense market. Business Opportunity The biodefense sector offers considerable growth opportunities for industry stakeholders. The demand for innovative technologies such as biosensors, early warning systems, and digital surveillance platforms is on the rise. Companies are focusing on developing scalable and cost-effective solutions to address diverse biological threats. The incorporation of artificial intelligence and machine learning is enabling predictive modeling and more efficient resource allocation. Emerging economies present lucrative opportunities due to increasing investments in healthcare infrastructure and defense preparedness. Strategic alliances, research collaborations, and government contracts are further enhancing the growth potential for market participants. Region Analysis North America continues to lead the global biodefense market, supported by strong government funding, advanced research capabilities, and the presence of major industry players. The region’s proactive approach to biosecurity and public health preparedness ensures sustained market growth. Europe holds a significant share, driven by collaborative initiatives and a focus on strengthening regional health security frameworks. Asia Pacific is emerging as a high-growth region, fueled by expanding healthcare systems, increasing awareness of biosecurity risks, and rising government investments in biodefense technologies. Countries such as China, India, and Japan are actively enhancing their preparedness against biological threats. Latin America and the Middle East and Africa are gradually strengthening their biodefense capabilities, supported by improving infrastructure and policy initiatives. Key Players • Emergent BioSolutions Inc. • XOMA Corporation • Altimmune Inc. • Dynavax Technologies Corporation • SIGA Technologies Inc. • Elusys Therapeutics Inc. • Ichor Medical Systems • DynPort Vaccine Company • Cleveland BioLabs Inc. • Bavarian Nordic A/S • Ology Bioservices Inc. • Alnylam Pharmaceuticals Inc. • GSK plc • Sanofi (Sanofi Pasteur) • PharmAthene Inc. Segmentation By Technology • UV Light • Gamma Radiation • Cold Plasma • Microwave Heating • Others By System • Digital Biosurveillance Networks • Early Warning Systems • Biohazard Detection Systems • AI-Assisted Surveillance System • Biosensors • Others By End User • Military Forces • Homeland Security • Hospitals & Clinics • Pharmaceutical & Biotech Companies • Virological Research Institutes By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Table of Contents1. Executive Summary1.1. Global Biodefense Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Biodefense Market Outlook, 2020-2033 3.1. Global Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 3.1.1. UV Light 3.1.2. Gamma Radiation 3.1.3. Cold Plasma 3.1.4. Microwave Heating 3.1.5. Others 3.2. Global Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 3.2.1. Digital Biosurveillance Networks 3.2.2. Early Warning Systems 3.2.3. Biohazard Detection Systems 3.2.4. AI-Assisted Surveillance System 3.2.5. Biosensors 3.2.6. Others 3.3. Global Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.3.1. Military Forces 3.3.2. Homeland Security 3.3.3. Hospitals & Clinics 3.3.4. Pharmaceutical & Biotech Companies 3.3.5. Virological Research Institutes 3.4. Global Biodefense Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America Biodefense Market Outlook, 2020-2033 4.1. North America Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 4.1.1. UV Light 4.1.2. Gamma Radiation 4.1.3. Cold Plasma 4.1.4. Microwave Heating 4.1.5. Others 4.2. North America Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 4.2.1. Digital Biosurveillance Networks 4.2.2. Early Warning Systems 4.2.3. Biohazard Detection Systems 4.2.4. AI-Assisted Surveillance System 4.2.5. Biosensors 4.2.6. Others 4.3. North America Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.3.1. Military Forces 4.3.2. Homeland Security 4.3.3. Hospitals & Clinics 4.3.4. Pharmaceutical & Biotech Companies 4.3.5. Virological Research Institutes 4.4. North America Biodefense Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. Biodefense Market Outlook, by Technology, 2020-2033 4.4.2. U.S. Biodefense Market Outlook, by System, 2020-2033 4.4.3. U.S. Biodefense Market Outlook, by End User, 2020-2033 4.4.4. Canada Biodefense Market Outlook, by Technology, 2020-2033 4.4.5. Canada Biodefense Market Outlook, by System, 2020-2033 4.4.6. Canada Biodefense Market Outlook, by End User, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe Biodefense Market Outlook, 2020-2033 5.1. Europe Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 5.1.1. UV Light 5.1.2. Gamma Radiation 5.1.3. Cold Plasma 5.1.4. Microwave Heating 5.1.5. Others 5.2. Europe Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 5.2.1. Digital Biosurveillance Networks 5.2.2. Early Warning Systems 5.2.3. Biohazard Detection Systems 5.2.4. AI-Assisted Surveillance System 5.2.5. Biosensors 5.2.6. Others 5.3. Europe Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.3.1. Military Forces 5.3.2. Homeland Security 5.3.3. Hospitals & Clinics 5.3.4. Pharmaceutical & Biotech Companies 5.3.5. Virological Research Institutes 5.4. Europe Biodefense Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany Biodefense Market Outlook, by Technology, 2020-2033 5.4.2. Germany Biodefense Market Outlook, by System, 2020-2033 5.4.3. Germany Biodefense Market Outlook, by End User, 2020-2033 5.4.4. Italy Biodefense Market Outlook, by Technology, 2020-2033 5.4.5. Italy Biodefense Market Outlook, by System, 2020-2033 5.4.6. Italy Biodefense Market Outlook, by End User, 2020-2033 5.4.7. France Biodefense Market Outlook, by Technology, 2020-2033 5.4.8. France Biodefense Market Outlook, by System, 2020-2033 5.4.9. France Biodefense Market Outlook, by End User, 2020-2033 5.4.10. U.K. Biodefense Market Outlook, by Technology, 2020-2033 5.4.11. U.K. Biodefense Market Outlook, by System, 2020-2033 5.4.12. U.K. Biodefense Market Outlook, by End User, 2020-2033 5.4.13. Spain Biodefense Market Outlook, by Technology, 2020-2033 5.4.14. Spain Biodefense Market Outlook, by System, 2020-2033 5.4.15. Spain Biodefense Market Outlook, by End User, 2020-2033 5.4.16. Russia Biodefense Market Outlook, by Technology, 2020-2033 5.4.17. Russia Biodefense Market Outlook, by System, 2020-2033 5.4.18. Russia Biodefense Market Outlook, by End User, 2020-2033 5.4.19. Rest of Europe Biodefense Market Outlook, by Technology, 2020-2033 5.4.20. Rest of Europe Biodefense Market Outlook, by System, 2020-2033 5.4.21. Rest of Europe Biodefense Market Outlook, by End User, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Biodefense Market Outlook, 2020-2033 6.1. Asia Pacific Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 6.1.1. UV Light 6.1.2. Gamma Radiation 6.1.3. Cold Plasma 6.1.4. Microwave Heating 6.1.5. Others 6.2. Asia Pacific Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 6.2.1. Digital Biosurveillance Networks 6.2.2. Early Warning Systems 6.2.3. Biohazard Detection Systems 6.2.4. AI-Assisted Surveillance System 6.2.5. Biosensors 6.2.6. Others 6.3. Asia Pacific Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.3.1. Military Forces 6.3.2. Homeland Security 6.3.3. Hospitals & Clinics 6.3.4. Pharmaceutical & Biotech Companies 6.3.5. Virological Research Institutes 6.4. Asia Pacific Biodefense Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China Biodefense Market Outlook, by Technology, 2020-2033 6.4.2. China Biodefense Market Outlook, by System, 2020-2033 6.4.3. China Biodefense Market Outlook, by End User, 2020-2033 6.4.4. Japan Biodefense Market Outlook, by Technology, 2020-2033 6.4.5. Japan Biodefense Market Outlook, by System, 2020-2033 6.4.6. Japan Biodefense Market Outlook, by End User, 2020-2033 6.4.7. South Korea Biodefense Market Outlook, by Technology, 2020-2033 6.4.8. South Korea Biodefense Market Outlook, by System, 2020-2033 6.4.9. South Korea Biodefense Market Outlook, by End User, 2020-2033 6.4.10. India Biodefense Market Outlook, by Technology, 2020-2033 6.4.11. India Biodefense Market Outlook, by System, 2020-2033 6.4.12. India Biodefense Market Outlook, by End User, 2020-2033 6.4.13. Southeast Asia Biodefense Market Outlook, by Technology, 2020-2033 6.4.14. Southeast Asia Biodefense Market Outlook, by System, 2020-2033 6.4.15. Southeast Asia Biodefense Market Outlook, by End User, 2020-2033 6.4.16. Rest of SAO Biodefense Market Outlook, by Technology, 2020-2033 6.4.17. Rest of SAO Biodefense Market Outlook, by System, 2020-2033 6.4.18. Rest of SAO Biodefense Market Outlook, by End User, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America Biodefense Market Outlook, 2020-2033 7.1. Latin America Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 7.1.1. UV Light 7.1.2. Gamma Radiation 7.1.3. Cold Plasma 7.1.4. Microwave Heating 7.1.5. Others 7.2. Latin America Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 7.2.1. Digital Biosurveillance Networks 7.2.2. Early Warning Systems 7.2.3. Biohazard Detection Systems 7.2.4. AI-Assisted Surveillance System 7.2.5. Biosensors 7.2.6. Others 7.3. Latin America Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.3.1. Military Forces 7.3.2. Homeland Security 7.3.3. Hospitals & Clinics 7.3.4. Pharmaceutical & Biotech Companies 7.3.5. Virological Research Institutes 7.4. Latin America Biodefense Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil Biodefense Market Outlook, by Technology, 2020-2033 7.4.2. Brazil Biodefense Market Outlook, by System, 2020-2033 7.4.3. Brazil Biodefense Market Outlook, by End User, 2020-2033 7.4.4. Mexico Biodefense Market Outlook, by Technology, 2020-2033 7.4.5. Mexico Biodefense Market Outlook, by System, 2020-2033 7.4.6. Mexico Biodefense Market Outlook, by End User, 2020-2033 7.4.7. Argentina Biodefense Market Outlook, by Technology, 2020-2033 7.4.8. Argentina Biodefense Market Outlook, by System, 2020-2033 7.4.9. Argentina Biodefense Market Outlook, by End User, 2020-2033 7.4.10. Rest of LATAM Biodefense Market Outlook, by Technology, 2020-2033 7.4.11. Rest of LATAM Biodefense Market Outlook, by System, 2020-2033 7.4.12. Rest of LATAM Biodefense Market Outlook, by End User, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Biodefense Market Outlook, 2020-2033 8.1. Middle East & Africa Biodefense Market Outlook, by Technology, Value (US$ Bn), 2020-2033 8.1.1. UV Light 8.1.2. Gamma Radiation 8.1.3. Cold Plasma 8.1.4. Microwave Heating 8.1.5. Others 8.2. Middle East & Africa Biodefense Market Outlook, by System, Value (US$ Bn), 2020-2033 8.2.1. Digital Biosurveillance Networks 8.2.2. Early Warning Systems 8.2.3. Biohazard Detection Systems 8.2.4. AI-Assisted Surveillance System 8.2.5. Biosensors 8.2.6. Others 8.3. Middle East & Africa Biodefense Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.3.1. Military Forces 8.3.2. Homeland Security 8.3.3. Hospitals & Clinics 8.3.4. Pharmaceutical & Biotech Companies 8.3.5. Virological Research Institutes 8.4. Middle East & Africa Biodefense Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC Biodefense Market Outlook, by Technology, 2020-2033 8.4.2. GCC Biodefense Market Outlook, by System, 2020-2033 8.4.3. GCC Biodefense Market Outlook, by End User, 2020-2033 8.4.4. South Africa Biodefense Market Outlook, by Technology, 2020-2033 8.4.5. South Africa Biodefense Market Outlook, by System, 2020-2033 8.4.6. South Africa Biodefense Market Outlook, by End User, 2020-2033 8.4.7. Egypt Biodefense Market Outlook, by Technology, 2020-2033 8.4.8. Egypt Biodefense Market Outlook, by System, 2020-2033 8.4.9. Egypt Biodefense Market Outlook, by End User, 2020-2033 8.4.10. Nigeria Biodefense Market Outlook, by Technology, 2020-2033 8.4.11. Nigeria Biodefense Market Outlook, by System, 2020-2033 8.4.12. Nigeria Biodefense Market Outlook, by End User, 2020-2033 8.4.13. Rest of Middle East Biodefense Market Outlook, by Technology, 2020-2033 8.4.14. Rest of Middle East Biodefense Market Outlook, by System, 2020-2033 8.4.15. Rest of Middle East Biodefense Market Outlook, by End User, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Emergent BioSolutions Inc. 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. XOMA Corporation 9.4.3. Altimmune Inc. 9.4.4. Dynavax Technologies Corporation 9.4.5. SIGA Technologies Inc. 9.4.6. Elusys Therapeutics Inc. 9.4.7. Ichor Medical Systems 9.4.8. DynPort Vaccine Company 9.4.9. Cleveland BioLabs Inc. 9.4.10. Bavarian Nordic A/S 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の 医薬品・バイオテクノロジー分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
